brentuximab vedotin
seagen,takeda
['equate', 't-cell lymphoma', 'hodgkin', 'brentuximab', 'fil,veral,12', 'peripheral t-cell lymphoma', 'lymphoma', 'imab ']
#ash22
abstract 164 academic cd30-car
enriched for memory t-cells (hsp-car30) are feasible and safe. preliminary data suggest that hsp-car30 shows antitumor efficacy, even in patients refractory to brentuximab and anti-pd-1. 
Hematologist at Saint Antoine Hospital, Paris, France @Sorbonne_Univ_ @APHP. @JACIE_EBMT National Representative. #BMTsm #LYMsm #CARTcell #CardioOnc #QoL